Meitheal Reveals Manufacturing Expansion Plans
Increasing Capacity To Produce Heparin Amid Supply Concerns
Executive Summary
Meithal Pharmaceuticals has revealed future plans to expand its manufacturing capabilities as the US FDA approved a new vial manufacturing line that will double the firm’s capacity to supply the US market.